Comparison between Basic and Inverse Dual Drug and Peptide-coated Stents in a Porcine Restenosis Model |
Jang, Eun-Jae
(Biopharmaceutical Research Center)
Lee, So-Youn (The Cardiovascular Convergence Research Center of Chonnam National University, Hospital Designated by Ministry of Health and Welfare) Bae, In-Ho (The Cardiovascular Convergence Research Center of Chonnam National University, Hospital Designated by Ministry of Health and Welfare) Park, Dae Sung (The Cardiovascular Convergence Research Center of Chonnam National University, Hospital Designated by Ministry of Health and Welfare) Jeong, Myung Ho (The Cardiovascular Convergence Research Center of Chonnam National University, Hospital Designated by Ministry of Health and Welfare) Park, Jun-Kyu (CGBio Co. Ltd) |
1 | M. Yu, B. Xu, D.E. Kandzari, Y. Wu, H. Yan, J. Chen, J. Qian, S. Qiao, Y. Yang, and R. L. Gao, First report of a novel polymer- free dual-drug eluting stent in de novo coronary artery disease: Results of the first in human BICARE trial, Catheter Cardiovasc. Interv., 83, 405-411 (2014). DOI |
2 | C. M. Matter, I. Rozenberg, A. Jaschko, H. Greutert, D. J. Kurz, S. Wnendt, B. Kuttler, H. Joch, J. Grunenfelder, G. Zund, F. C. Tanner, and T. F. Luscher, Effects of tacrolimus or sirolimus on proliferation of vascular smooth muscle and endothelial cells, J. Cardiovasc. Pharmacol., 48, 286-292 (2006). DOI |
3 | A. Curcio, D. Torella, and C. Indolfi, Mechanisms of smooth muscle cell proliferation and endothelial regeneration after vascular injury and stenting: approach to therapy, Circ. J., 75, 1287-1296 (2011). DOI |
4 | Y. Le, W. Gong, B. Li, N. M. Dunlop, W. Shen, S. B. Su, R. D. Ye, and J. M. Wang, Utilization of two seven-transmembrane, G protein-coupled receptors, formyl peptide receptor-like 1 and formyl peptide receptor, by the synthetic hexapeptide WKYMVm for human phagocyte activation, J. Immunol., 163, 6777-6784 (1999). |
5 | J. K. Seo, S. Y. Choi, Y. Kim, S. H. Baek, K. T. Kim, C. B. Chae, J. D. Lambeth, P. G. Suh, and S. H. Ryu, A peptide with unique receptor specificity: Stimulation of phosphoinositide hydrolysis and induction of superoxide generation in human neutrophils, J. Immunol., 158, 1895-1901 (1997). |
6 | S. C. Heo, Y. W. Kwon, I. H. Jang, G. O. Jeong, J. W. Yoon, C. D. Kim, S. M. Kwon, Y. S. Bae, and J. H. Kim, WKYMVm-induced activation of formyl peptide receptor 2 stimulates ischemic neovasculogenesis by promoting homing of endothelial colony-forming cells, Stem Cells, 32, 779-790 (2014). DOI |
7 | E. J. Jang, I. H. Bae, D. S. Park, S. Y. Lee, K. S. Lim, J. K. Park, J. W. Shim, D. S. Sim, and M. H. Jeong, Effect of a novel peptide, WKYMVm- and sirolimus-coated stent on re-endothelialization and anti-restenosis, J. Mater. Sci. Mater. Med., 26, 251 (2015). DOI |
8 | P. Buszman, S. Trznadel, A. Zurakowski, K. Milewski, L. Kinasz, M. Krol, and M. Kondys, Prospective registry evaluating safety and efficacy of cobalt-chromium stent implantation in patients with de novo coronary lesions, Kardiol. Pol., 65, 1041-1048 (2007). |
9 | S. Y. Lee, I. H. Bae, D. S. Park, E. J. Jang, J. W. Shim, K. S. Lim, J. K. Park, D. S. Sim, and M. H. Jeong, Comparison of dextran-based sirolimus-eluting stents and PLA-based sirolimus-eluting stents in vitro and in vivo, J. Biomed. Mater. Res. A, 105, 301-310 (2017). DOI |
10 | I. H. Bae, K. S. Lim, J. K. Park, D. S. Park, S. Y. Lee, E. J. Jang, M. S. Ji, D. S. Sim, Y. J. Hong, Y. Ahn, J. C. Park, J. G. Cho, J. C. Kang, I. S. Kim, J. W. Nah, and M. H. Jeong, Mechanical behavior and in vivo properties of newly designed bare metal stent for enhanced flexibility, J. Ind. Eng. Chem., 21, 1295-1300 (2015). DOI |
11 | National Research Council (U.S.), Committee for the Update of the Guide for the Care and Use of Laboratory Animals., Institute for Laboratory Animal Research (U.S.), National Academies Press (U.S.), Guide for the care and use of laboratory animals, National Academies Press,, Washington, D.C., 2011, pp. xxv, p. 220. |
12 | R. S. Schwartz, K. C. Huber, J. G. Murphy, W. D. Edwards, A. R. Camrud, R. E. Vlietstra, and D. R. Holmes, Restenosis and the proportional neointimal response to coronary artery injury: Results in a porcine model, J. Am. Coll. Cardiol., 19, 267-274 (1992). DOI |
13 | M. H. Chen, P. C. Liang, K. C. Chang, J. Y. Huang, Y. T. Chang, F. Y. Chang, J. M. Wong, and F. H. Lin, Prototype of biliary drug-eluting stent with photodynamic and chemotherapy using electrospinning, Biomed. Eng. Online, 13, 118 (2014). DOI |
14 | Y. H. Choi, S. C. Heo, Y. W. Kwon, H. D. Kim, S. H. Kim, I. H. Jang, J. H. Kim, and N. S. Hwang, Injectable PLGA microspheres encapsulating WKYMVM peptide for neovascularization, Acta Biomater., 25, 76-85 (2015). DOI |
15 | W. Ye, Q. Shi, J. W. Hou, J. Jin, Q. F. Fan, S. C. Wong, X. D. Xu, and J. H. Yin, Superhydrophobic coating of elastomer on different substrates using a liquid template to construct a biocompatible and antibacterial surface, J. Mater. Chem. B, 2, 7186-7191 (2014). DOI |
16 | A. Tan, Y. Farhatnia, A. de Mel, J. Rajadas, M. S. Alavijeh, and A. M. Seifalian, Inception to actualization: Next generation coronary stent coatings incorporating nanotechnology, J. Biotechnol., 164, 151-170 (2013). DOI |
17 | H. Chang, K. F. Ren, H. Zhang, J. L. Wang, B. L. Wang, and J. Ji, The (PrS/HGF-pDNA) multilayer films for gene-eluting stent coating: Gene-protecting, anticoagulation, antibacterial properties, and in vivo antirestenosis evaluation, J. Biomed. Mater. Res. B Appl. Biomater., 103, 430-439 (2015). DOI |
18 | X. Ma, S. Oyamada, F. Gao, T. Wu, M. P. Robich, H. Wu, X. Wang, B. Buchholz, S. McCarthy, Z. Gu, C. F. Bianchi, F. W. Sellke, and R. Laham, Paclitaxel/sirolimus combination coated drug-eluting stent: In vitro and in vivo drug release studies, J. Pharm. Biomed. Anal., 54, 807-811 (2011). DOI |
19 | Y. Huang, S. S. Venkatraman, F. Y. Boey, E. M. Lahti, P. R. Umashankar, M. Mohanty, S. Arumugam, L. Khanolkar, and S. Vaishnav, In vitro and in vivo performance of a dual drug-eluting stent (DDES), Biomaterials, 31, 4382-4391, (2010). DOI |
20 | A. W. Heldman, L. Cheng, G. M. Jenkins, P. F. Heller, D. W. Kim, M. Ware, Jr., C. Nater, R. H. Hruban, B. Rezai, B. S. Abella, K. E. Bunge, J. L. Kinsella, S. J. Sollott, E. G. Lakatta, J. A. Brinker, W. L. Hunter, and J. P. Froehlich, Paclitaxel stent coating inhibits neointimal hyperplasia at 4 weeks in a porcine model of coronary restenosis, Circulation, 103, 2289-2295 (2001). DOI |
21 | M. Shuchman, Trading restenosis for thrombosis? New questions about drug-eluting stents, N. Engl. J. Med., 355, 1949-1952 (2006). DOI |
22 | A. Kivela and J. Hartikainen, Restenosis related to percutaneous coronary intervention has been solved?, Ann. Med., 38, 173-187 (2006). DOI |
23 | Q. Lin, X. Ding, F. Qiu, X. Song, G. Fu, and J. Ji, In situ endothelialization of Intravascular stents coated with an anti-CD34 antibody functionalized heparin-collagen multilayer, Biomaterials, 31, 4017-4025 (2010). DOI |
24 | J. J. Kleinedler, J. D. Foley, E. A. Orchard, and T. R. Dugas, Novel nanocomposite stent coating releasing resveratrol and quercetin reduces neointimal hyperplasia and promotes re-endothelialization, J. Control. Release, 159, 27-33 (2012). DOI |
25 | H. Tang, Q. Wang, X. Wang, J. Zhou, M. Zhu, T. Qiao, C. Liu, C. Mao, and M. Zhou, Effect of a Novel stent on re-endothelialization, platelet adhesion, and neointimal formation, J. Atheroscler. Thromb., 23, 67-80 (2016). DOI |
26 | G. Nakazawa, J. F. Granada, C. L. Alviar, A. Tellez, G. L. Kaluza, M. Y. Guilhermier, S. Parker, S. M. Rowland, F. D. Kolodgie, and M. B. Leon, R. Virmani, Anti-CD34 antibodies immobilized on the surface of sirolimus-eluting stents enhance stent endothelialization, JACC Cardiovasc. Interv., 3, 68-75 (2010). DOI |
27 | M. R. Bennett, Vascular pathology as a result of drug-eluting stents, Heart, 93, 895-896 (2007). DOI |
28 | P. Roopmani, S. Satheesh, D. C. Raj, and U. M. Krishnan, Development of dual drug eluting cardiovascular stent with ultrathin flexible poly(l-lactide-co-caprolactone) coating, ACS Biomater. Sci. Eng., 5(6), 2899-2915 (2019). DOI |